Dr. Madala Ravikrishna, Medical Oncologist
MBBS, MD (Radiation) , DM (Medical Oncology)
Medical Oncologist
Dr. Madala Ravikrishna Appointment and Practice Location
Metro Pillar No C1327, Beside Jamia Masjid, Prakash Nagar,
Begumpet, Hyderabad
Get Directions
OP Timings
Mon - Sat
09:00 am - 04:00 pm
Fee: 750
- Practice Locations (1)
- Profile
- Patient Reviews
- Q&A
- Media
Specializations
Medical Oncologist
Haemato Oncologist
Expertises
- Biliary and Pancreatic Cancer
- Brain Tumors
- Breast Cancer
- Cancer Screening
- Cervical Cancers
- Colorectal Cancers
- Medical Oncology
Qualifications
- MBBS - Kurnool Medical College - 2013 - Kurnool
- MD - Radiotherapy - Sri Venkateswara Institute Of Medical Sciences - 2018 - Tirupati
- DM - Medical Oncology - Tata Memorial Hospital - 2022 - Maharashtra
Experiences
- Internship Kurnool Medical College
- Senior Resident - Department of Radiation Oncology Venkata Padmavathi Institute of Medical Sciences - Tirupati
- Assistant Professor Tata Memorial Centre - Mumbai
- Consultant Medical Oncologist Kims Hospital - Begumpet - Currently Working
Registrations
- 81137 Telangana State Medical Council 2013
Paper Presentations
- Patil V, Abraham G, Ravikrishna M, Bhattacharjee A, Noronha V, Parekh D, Menon N, Bajpai J, Prabhash K. Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India.
- Bajpai J, Panda G, Ravikrishna M, Chandrasekharan A, Rekhi B, Bhargava P, Srinivas S, Laskar S, Mokal S, Khanna N, Patil V. Vascular endothelial growth factor as a potential prognosticator in Ewing Sarcoma: a tertiary care cancer centre experience from India.
- Madala RK, Krishnatry R, Noronha V, Patil V, Joshi A, Menon N, Muthuluri H, Prabhash K. Neurological deterioration in a patient with lung cancer and brain metastasis. Cancer
- Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A. Results of phase III randomised trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation. Journal of Clinical Oncology. 2023 Jan:JCO-22.
- Prathipati A, Jilla S, Subramanian BV, Madala RK. Impact of Various Prognostic Factors on Overall Survival, Disease-Free Survival and Patterns of Failure in Carcinoma Cervix: A Tertiary Care Centre Experience from South India. Indian Journal of Gynecologic Oncology. 2018 Mar;16:1-4.
Report an error
Dr. Madala Ravikrishna, Medical Oncologist Reviews
No feedback available for this Doctor.
Be the first to write a review.
Question & Answers by Dr. Madala Ravikrishna
No Question & Answers by this doctor.
Media from Dr. Madala Ravikrishna
No Videos updated by this doctor.
